Business Description
Korean Drug Co Ltd
ISIN : KR7014570006
Compare
Compare
Traded in other countries / regions
014570.Korea IPO Date
2000-12-07Description
Korean Drug Co Ltd is engaged in manufacturing and marketing of pharmaceutical products in South Korea. Its products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 247.96 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 5974.77 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.4 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.1 | |||||
| 3-Year EBITDA Growth Rate | -1.6 | |||||
| 3-Year EPS without NRI Growth Rate | -25.1 | |||||
| 3-Year Book Growth Rate | 3.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.72 | |||||
| 9-Day RSI | 45.07 | |||||
| 14-Day RSI | 45.76 | |||||
| 6-1 Month Momentum % | 1.2 | |||||
| 12-1 Month Momentum % | 2.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.41 | |||||
| Quick Ratio | 4.55 | |||||
| Cash Ratio | 1.69 | |||||
| Days Inventory | 129.82 | |||||
| Days Sales Outstanding | 131.63 | |||||
| Days Payable | 26.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.28 | |||||
| Dividend Payout Ratio | 0.34 | |||||
| Forward Dividend Yield % | 2.28 | |||||
| 5-Year Yield-on-Cost % | 3.98 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 2.28 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.9 | |||||
| Operating Margin % | 22.15 | |||||
| Net Margin % | -6.04 | |||||
| FCF Margin % | -9.75 | |||||
| ROE % | -5.96 | |||||
| ROA % | -4.89 | |||||
| ROIC % | -17.83 | |||||
| ROC (Joel Greenblatt) % | 16.23 | |||||
| ROCE % | 9.69 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 14.73 | |||||
| Shiller PE Ratio | 13.38 | |||||
| Price-to-Owner-Earnings | 11.62 | |||||
| PEG Ratio | 1.26 | |||||
| PS Ratio | 0.87 | |||||
| PB Ratio | 0.92 | |||||
| Price-to-Tangible-Book | 0.93 | |||||
| EV-to-EBIT | 6.58 | |||||
| EV-to-EBITDA | 5.43 | |||||
| EV-to-Revenue | 0.67 | |||||
| EV-to-FCF | -6.86 | |||||
| Price-to-Projected-FCF | 0.78 | |||||
| Price-to-DCF (Earnings Based) | 0.43 | |||||
| Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.69 | |||||
| Price-to-Graham-Number | 0.91 | |||||
| Price-to-Net-Current-Asset-Value | 1.4 | |||||
| Price-to-Net-Cash | 17.18 | |||||
| Earnings Yield (Greenblatt) % | 15.2 | |||||
| FCF Yield % | -11.16 | |||||
| Forward Rate of Return (Yacktman) % | 23.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korean Drug Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 81,374.983 | ||
| EPS (TTM) (â‚©) | -456 | ||
| Beta | 0.68 | ||
| Volatility % | 20.35 | ||
| 14-Day RSI | 45.76 | ||
| 14-Day ATR (â‚©) | 166.946306 | ||
| 20-Day SMA (â‚©) | 6692 | ||
| 12-1 Month Momentum % | 2.75 | ||
| 52-Week Range (â‚©) | 5870 - 7980 | ||
| Shares Outstanding (Mil) | 10.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korean Drug Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korean Drug Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korean Drug Co Ltd Frequently Asked Questions
What is Korean Drug Co Ltd(XKRX:014570)'s stock price today?
The current price of XKRX:014570 is â‚©6590.00. The 52 week high of XKRX:014570 is â‚©7980.00 and 52 week low is â‚©5870.00.
When is next earnings date of Korean Drug Co Ltd(XKRX:014570)?
The next earnings date of Korean Drug Co Ltd(XKRX:014570) is .
Does Korean Drug Co Ltd(XKRX:014570) pay dividends? If so, how much?
The Dividend Yield %  of Korean Drug Co Ltd(XKRX:014570) is 2.28% (As of Today), Highest Dividend Payout Ratio of Korean Drug Co Ltd(XKRX:014570) was 0.45. The lowest was 0.16. And the median was 0.25. The  Forward Dividend Yield % of Korean Drug Co Ltd(XKRX:014570) is 2.28%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers